(Q44358646)

2 December 2017

title

Citicoline in stroke and TBI clinical trials (English)

1 reference

2 December 2017

author name string

Rao Muralikrishna Adibhatla

series ordinal

1

1 reference

2 December 2017

language of work or name

English

0 references

publication date

29 January 2013

1 reference

2 December 2017

published in

Nature Reviews Neurology

1 reference

2 December 2017

volume

9

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

173

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2012.166-c1

2 December 2017

exact match

0 references

cites work

Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial).

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

Citicoline in pre-clinical animal models of stroke: a meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

Effective treatment of traumatic brain injury: learning from experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

Mannosylated liposomal cytidine 5' diphosphocholine prevent age related global moderate cerebral ischemia reperfusion induced mitochondrial cytochrome c release in aged rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

Effect of oral CDP-choline on plasma choline and uridine levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

Role of Lipids in Brain Injury and Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

Stroke: Treatment for acute stroke--the end of the citicoline saga

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

Enhanced therapeutic effect of cytidine-5'-diphosphate choline when associated with GM1 containing small liposomes as demonstrated in a rat ischemia model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

Serial MRI study of the enhanced therapeutic effects of liposome-encapsulated citicoline in cerebral ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.166-C1

10.1038/NRNEUROL.2012.166-C1

31 March 2020

Identifiers

DOI

1 reference

2 December 2017

1 reference